All Stories

  1. A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area

    Article • PLoS ONE, February 2020, PLOS

    F. Xavier López-Labrador

  2. Natural HCV resitance to DAA

    Article • Antimicrobial Agents and Chemotherapy, February 2016, ASM Journals

    F. Xavier López-Labrador

  3. New developments in the management of hepatitis C virus infection: focus on boceprevir

    Article • Biologics Targets & Therapy, August 2012, Taylor & Francis

    F. Xavier López-Labrador

  4. Boceprevir in the treatment of chronic hepatitis C virus infection

    Article • Virus Adaptation and Treatment, February 2011, Taylor & Francis

    F. Xavier López-Labrador